Biotron (ASX:BIT) raised AU$1.3 million through the completion of its renounceable rights issue, according to a Tuesday filing with the Australian bourse.
The company will issue 424.9 million new fully paid ordinary shares, with AU$668,336 raised from rights taken up and AU$606,253 from shortfall shares, the filing said.
Proceeds will be used to support Biotron's commercialization efforts, as well as general working capital, the filing added.
The new shares will be issued on April 8, the company said.
Mahe Capital was the lead manager and underwriter for the rights issue.
Shares of the company declined 13% in recent Tuesday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。